The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, following a 600 mg oral dose. The levels of the compound were measured by a microbiological assay in serum, blister fluid and urine. The compound was rapidly absorbed, the mean maximum concentration of ofloxacin being 10-7 mg/1 at 1-2 h. The mean serum elimination half-life was 7 h and 80-3% of the administered compound was recovered in the urine by 48 h. Ofloxacin penetrated the blister fluid well, the mean peak level being 5-2 mg/1 at 5-3 h
The purpose of the study was to evaluate the pharmacokinetic characteristics of a single, intravenou...
OBJECTIVE: To evaluate the pharmacokinetic profile of ofloxacin in healthy volunteers after single ...
The bioavailability of two ofloxacin (OFX) tablet formulations (OTT, test formulation from Laborator...
The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dos...
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norf...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
The pharmacokinetics and tissue penetration of five quinolones into inflammatory exudate were studie...
The bioequivalence of oral and intravenous ofloxacin was investigated after the administration of mu...
In ten volunteers the pharmacokinetics of ofloxacin and ciprofloxacin were determined after crossove...
The disposition kinetics of ofloxacin, a quinolone antibacterial agent excreted essentially unmodifi...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
A study was performed to establish the effect of A13+ and Fe24 cations on the absorption of ofloxaci...
Ofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic aci...
Objective: To study the pharmacokinetics of ofloxacin using salivary drug concentration when adminis...
A single 400-mg oral dose of grepafloxacin (OPC-17116) was given to each of six healthy male volunte...
The purpose of the study was to evaluate the pharmacokinetic characteristics of a single, intravenou...
OBJECTIVE: To evaluate the pharmacokinetic profile of ofloxacin in healthy volunteers after single ...
The bioavailability of two ofloxacin (OFX) tablet formulations (OTT, test formulation from Laborator...
The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dos...
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norf...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
The pharmacokinetics and tissue penetration of five quinolones into inflammatory exudate were studie...
The bioequivalence of oral and intravenous ofloxacin was investigated after the administration of mu...
In ten volunteers the pharmacokinetics of ofloxacin and ciprofloxacin were determined after crossove...
The disposition kinetics of ofloxacin, a quinolone antibacterial agent excreted essentially unmodifi...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
A study was performed to establish the effect of A13+ and Fe24 cations on the absorption of ofloxaci...
Ofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic aci...
Objective: To study the pharmacokinetics of ofloxacin using salivary drug concentration when adminis...
A single 400-mg oral dose of grepafloxacin (OPC-17116) was given to each of six healthy male volunte...
The purpose of the study was to evaluate the pharmacokinetic characteristics of a single, intravenou...
OBJECTIVE: To evaluate the pharmacokinetic profile of ofloxacin in healthy volunteers after single ...
The bioavailability of two ofloxacin (OFX) tablet formulations (OTT, test formulation from Laborator...